XNYSELV
Market cap86bUSD
Dec 24, Last price
372.94USD
1D
1.35%
1Q
-29.67%
Jan 2017
157.97%
Name
Elevance Health Inc
Chart & Performance
Profile
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as pharmacy benefits management, dental, vision, life and disability insurance benefits, and analytics-driven personal health care. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2021, it served 45 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
IPO date
Oct 30, 2001
Employees
102,300
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 171,340,000 9.42% | 156,595,000 12.95% | 138,639,000 13.76% | |||||||
Cost of revenue | 17,293,000 | 13,035,000 | 10,895,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 154,047,000 | 143,560,000 | 127,744,000 | |||||||
NOPBT Margin | 89.91% | 91.68% | 92.14% | |||||||
Operating Taxes | 1,724,000 | 1,750,000 | 1,830,000 | |||||||
Tax Rate | 1.12% | 1.22% | 1.43% | |||||||
NOPAT | 152,323,000 | 141,810,000 | 125,914,000 | |||||||
Net income | 5,987,000 1.58% | 5,894,000 -4.29% | 6,158,000 34.69% | |||||||
Dividends | (1,395,000) | (1,229,000) | (1,104,000) | |||||||
Dividend yield | 1.25% | 0.99% | 0.97% | |||||||
Proceeds from repurchase of equity | (2,524,000) | (2,113,000) | 4,096,000 | |||||||
BB yield | 2.25% | 1.70% | -3.58% | |||||||
Debt | ||||||||||
Debt current | 1,874,000 | 1,765,000 | 1,874,000 | |||||||
Long-term debt | 23,931,000 | 23,100,000 | 22,021,000 | |||||||
Deferred revenue | 1,112,000 | 1,153,000 | ||||||||
Other long-term liabilities | 2,516,000 | 1,187,000 | (1,153,000) | |||||||
Net debt | 13,172,000 | (10,179,000) | (36,032,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 8,061,000 | 8,399,000 | 8,364,000 | |||||||
CAPEX | (1,296,000) | (1,152,000) | (1,087,000) | |||||||
Cash from investing activities | (5,572,000) | (4,560,000) | (9,638,000) | |||||||
Cash from financing activities | (3,349,000) | (1,318,000) | 423,000 | |||||||
FCF | 148,993,000 | 146,428,000 | 121,822,000 | |||||||
Balance | ||||||||||
Cash | 6,526,000 | 7,387,000 | 31,147,000 | |||||||
Long term investments | 6,107,000 | 27,657,000 | 28,780,000 | |||||||
Excess cash | 4,066,000 | 27,214,250 | 52,995,050 | |||||||
Stockholders' equity | 30,537,000 | 27,310,000 | 26,980,000 | |||||||
Invested Capital | 62,975,000 | 35,592,750 | 69,549,000 | |||||||
ROIC | 309.07% | 269.75% | 192.40% | |||||||
ROCE | 223.22% | 221.40% | 128.80% | |||||||
EV | ||||||||||
Common stock shares outstanding | 237,400 | 242,800 | 246,800 | |||||||
Price | 471.56 -8.07% | 512.97 10.66% | 463.54 44.36% | |||||||
Market cap | 111,948,344 -10.12% | 124,549,116 8.87% | 114,401,672 40.11% | |||||||
EV | 125,219,344 | 114,457,116 | 78,437,672 | |||||||
EBITDA | 155,792,000 | 145,235,000 | 129,046,000 | |||||||
EV/EBITDA | 0.80 | 0.79 | 0.61 | |||||||
Interest | 1,030,000 | 851,000 | 798,000 | |||||||
Interest/NOPBT | 0.67% | 0.59% | 0.62% |